Qualigen Therapeutics Inc.
QLGN | NASDAQ
$3.21
+$0.17 (+5.59%)
At close: Nov 18, 2025, 04:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 577.33K | 6.2M | 19.33M | 38.78M | 331.6K | 30.21K | 1.17M | 388.15K | 118.69K | 93.22K | 401.8K | 2.07M | 1.34M | 4.36M | 3.17M | 6.62M | 9.75M | 13.61M | 17.54M | 12.32M | 15.23M | 21.95M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.43K | 5.59K | n/a | 5.62K | 5.72K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 380.4K | 10.35K | 10.35K | 2K | 2K | 2K | 2K | n/a | n/a | n/a | 866.48K | 866.48K | 23.77K | 23.92K | 1.77M | 23.96K | 24.05K | 18.33K | 18.33K | 18.33K | 18.33K | 18.33K |
Receivables | n/a | 385.43K | 343.06K | 4.35M | 3.31M | 2.23M | 2.01M | 1.3M | n/a | n/a | n/a | 235.4K | 679.38K | 411.1K | 538.59K | 603.29K | 719.88K | 594.34K | 822.35K | 633.55K | 766.91K | 862.24K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.56M | 1.48M | 1.59M | 1.48M | 1.31M | 1.4M | 1.06M | 1.18M | 1.07M | 885.86K |
Other Current Assets | 5.76M | 6.25M | 11.28M | 4.35M | 40.04K | 73.19K | 31.2K | 0 | 0 | 450K | 0 | n/a | 11.64K | 12.16K | 4.16M | n/a | n/a | n/a | 3.58K | n/a | 1 | 0 |
Total Current Assets | 6.34M | 23.49M | 30.95M | 43.47M | 3.96M | 2.85M | 4.68M | 2.31M | 534.41K | 1M | 1.17M | 3.45M | 4.86M | 7.54M | 10.82M | 10.4M | 13.7M | 16.7M | 20.8M | 15.73M | 19.11M | 24.92M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.88M | 1.96M | 26.24K | 1.79M | 1.87M | 1.82M | 1.85M | 475.79K | 580.16K | 612.24K |
Goodwill & Intangibles | 685.39K | 406.15K | 314.73K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.38M | 6.39M | 6.47M | 10.75M | 10.75M | 164.82K | 171.19K | 177.56K | 183.93K | 189.29K |
Total Long-Term Assets | 1.07M | 416.5K | 325.08K | 2K | 2K | 2K | 2K | n/a | n/a | n/a | 866.48K | 866.48K | 8.29M | 8.38M | 8.26M | 12.56M | 12.64M | 2M | 2.04M | 671.69K | 782.42K | 819.86K |
Total Assets | 7.4M | 23.9M | 31.28M | 43.47M | 3.96M | 2.85M | 4.69M | 2.31M | 534.41K | 1M | 2.03M | 4.32M | 13.15M | 15.91M | 19.08M | 22.96M | 26.35M | 18.71M | 22.84M | 16.4M | 19.89M | 25.74M |
Account Payables | 1.29M | 1.48M | 1.26M | 1.28M | 1.4M | 1.53M | 1.57M | 1.64M | 1.85M | 1.8M | 2.22M | 1.57M | 1.76M | 899.95K | 619.57K | 596.04K | 918.33K | 997.41K | 886.22K | 908.7K | 784.47K | 485.55K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 94.47K | 112.9K | 116.16K | 102.64K | 109.83K | 127.3K | 135.06K | 270.76K | 325.99K | 381.37K |
Short-Term Debt | 39.56K | n/a | 142.24K | 3.24M | 3.62M | 843.62K | n/a | 1.43M | 1.67M | 1.02M | 1.3M | 832.1K | 2.03M | 1.77M | 60.2K | 1.14M | 1.12M | 155.53K | n/a | 278.9K | 270.64K | 273.28K |
Other Current Liabilities | 394.47K | 551.96K | 3.19M | 362.32K | 313.18K | 288.95K | 269.18K | 908.62K | 573.22K | 885.47K | 63.45K | 2.29M | 3.41M | 4.52M | 6.62M | 2.13M | 2.71M | 1.9M | 1.7M | 3.3M | 5.52M | 7.72M |
Total Current Liabilities | 1.72M | 2.03M | 3.33M | 4.92M | 5.61M | 2.81M | 2.01M | 4.45M | 4.81M | 4.52M | 4.14M | 5.96M | 8.49M | 8.24M | 8.61M | 4.88M | 5.65M | 3.63M | 4.64M | 5.43M | 7.42M | 9.2M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | 1.35M | 1.47M | 1.71M | 2.16M | 2.23M | 1.57M | 1.64M | 131.49K | 210.2K | 308.41K |
Total Liabilities | 1.72M | 2.03M | 3.33M | 4.92M | 5.61M | 2.81M | 2.01M | 4.45M | 4.81M | 4.52M | 4.14M | 5.96M | 9.84M | 9.71M | 10.32M | 7.04M | 7.88M | 5.19M | 6.27M | 5.56M | 7.63M | 9.51M |
Total Debt | 39.56K | n/a | 142.24K | 3.24M | 3.62M | 843.62K | n/a | 1.43M | 1.67M | 1.02M | 1.3M | 832.1K | 3.46M | 3.25M | 1.76M | 2.7M | 2.72M | 1.64M | 1.68M | 303.89K | 368.79K | 446.46K |
Book Value | 5.68M | 21.87M | 27.95M | 38.55M | -1.65M | 33.13K | 2.68M | -2.14M | -4.28M | -3.52M | -2.1M | -1.64M | 3.31M | 6.2M | 8.77M | 15.92M | 18.47M | 13.52M | 16.56M | 10.85M | 12.26M | 16.23M |
Book Value Per Share | 0.28 | 2.84 | 11.61 | 22.89 | -0.98 | 0.02 | 0.59 | -0.47 | -0.56 | -0.59 | -0.40 | -0.32 | 0.65 | 1.25 | 2.08 | 4.03 | 5.04 | 3.83 | 5.29 | 3.74 | 4.25 | 5.76 |
Common Stock | 84.81K | 84.81K | 69.74K | 67.73K | 66.21K | 66.2K | 65.31K | 65.31K | 47.51K | 44.4K | 43.26K | 42.95K | 42.95K | 42.95K | 42.11K | 42.11K | 38.8K | 35.3K | 35.29K | 29.08K | 28.9K | 28.83K |
Retained Earnings | -150.29M | -146.11M | -140.03M | -129.43M | -127.39M | -125.71M | -123.06M | -122.21M | -120.41M | -118.84M | -116.8M | -114.35M | -110.7M | -107.23M | -103.39M | -97.01M | -93.19M | -89.06M | -84.74M | -78.68M | -75.83M | -70.52M |
Comprehensive Income | -12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 131.89K | 170.44K | 50.72K | 154.06K | 65.54K | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 5.68M | 21.87M | 27.95M | 38.55M | -1.65M | 33.13K | 2.68M | -2.14M | -4.28M | -3.52M | -2.1M | -1.64M | 2.03M | 4.87M | 7.24M | 12.15M | 14.47M | 13.52M | 16.56M | 10.85M | 12.26M | 16.23M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.43K | 5.59K | n/a | 5.62K | 5.72K | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove QLGN